Cannabis Bioscience International Holdings, Inc. (CBIH)
| Previous Close | 0.0006 |
| Open | 0.0006 |
| Bid | N/A x N/A |
| Ask | N/A x N/A |
| Day's Range | 0.0006 - 0.0007 |
| 52 Week Range | 0.0003 - 0.0018 |
| Volume | |
| Avg. Volume | 3,308,026 |
| Market Cap | 6.748M |
| Beta (5Y Monthly) | -0.02 |
| PE Ratio (TTM) | 0.07 |
| EPS (TTM) | 0.0100 |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
NewsfileCBIH Welcomes New Treasurer and Director, Mr. John E. Jones
Houston, Texas--(Newsfile Corp. - May 6, 2024) - Cannabis Bioscience International Holdings (OTC Pink: CBIH), a leading company in the cannabis industry, proudly announces Mr. John E. Jones as its new Treasurer and Director. Mr. Jones is a former 101st Airborne Division sergeant, with an illustrious 35-year career in the business sector, growing an iconic QSR's presence by 80 additional locations as a Franchise Partner, Operator and Chief Executive Officer. Led by his direction, ...
NewsfileCBIH Commences Clinical Trials of Osteoarthritis Injection "Orthocann"
Houston, Texas--(Newsfile Corp. - March 20, 2024) - Cannabis Bioscience International Holdings, Inc. (OTC Pink: CBIH) has announced the enrollment of the first patient for the clinical trial of its new intra-articular cannabinoid-based injection for knee osteoarthritis. The company plans to test the product on its first participant, and after careful collection and analysis of clinical outcomes, start enrollment of a bigger sample of patients to administer the treatment and further evaluate its
NewsfileCBIH Announces the Retirement of One Billion Shares
Houston, Texas--(Newsfile Corp. - March 6, 2024) - Cannabis Bioscience International Holdings, Inc. (OTC Pink: CBIH) announces that Dante Picazo, its chief executive officer, is contributing one billion shares of his common stock to the Company. These shares will be retired and have the status of authorized and unissued shares. As a result of this contribution, the number of the Company's outstanding shares has been reduced to approximately 9.4 billion. Since current management ...
